Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Long-term (6 and 12 months) follow-up of two prospective, randomized, controlled phase III trials of photodynamic therapy with BF-200 ALA and methyl aminolaevulinate for the treatment of actinic keratosis.

Dirschka T, Radny P, Dominicus R, Mensing H, Brüning H, Jenne L, Karl L, Sebastian M, Oster-Schmidt C, Klövekorn W, Reinhold U, Tanner M, Gröne D, Deichmann M, Simon M, Hübinger F, Hofbauer G, Krähn-Senftleben G, Borrosch F, Reich K, Berking C, Wolf P, Lehmann P, Moers-Carpi M, Hönigsmann H, Wernicke-Panten K, Hahn S, Pabst G, Voss D, Foguet M, Schmitz B, Lübbert H, Szeimies RM; AK-CT002 Study Group; AK-CT003 Study Group.

Br J Dermatol. 2013 Apr;168(4):825-36. doi: 10.1111/bjd.12158.

2.

Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placebo.

Dirschka T, Radny P, Dominicus R, Mensing H, Brüning H, Jenne L, Karl L, Sebastian M, Oster-Schmidt C, Klövekorn W, Reinhold U, Tanner M, Gröne D, Deichmann M, Simon M, Hübinger F, Hofbauer G, Krähn-Senftleben G, Borrosch F, Reich K, Berking C, Wolf P, Lehmann P, Moers-Carpi M, Hönigsmann H, Wernicke-Panten K, Helwig C, Foguet M, Schmitz B, Lübbert H, Szeimies RM; AK-CT002 Study Group.

Br J Dermatol. 2012 Jan;166(1):137-46. doi: 10.1111/j.1365-2133.2011.10613.x. Epub 2011 Dec 21.

PMID:
21910711
3.

Cutaneous macroglobulinosis deposits in a patient with IgM paraproteinemia/incipient Waldenström macroglobulinemia.

Lüftl M, Sauter-Jenne B, Gramatzki M, Eckert F, Jenne L.

J Dtsch Dermatol Ges. 2010 Dec;8(12):1000-3. doi: 10.1111/j.1610-0387.2010.07392.x. English, German.

PMID:
20202045
4.

Vaccinia virus impairs directional migration and chemokine receptor switch of human dendritic cells.

Humrich JY, Thumann P, Greiner S, Humrich JH, Averbeck M, Schwank C, Kämpgen E, Schuler G, Jenne L.

Eur J Immunol. 2007 Apr;37(4):954-65.

6.

Mature monocyte-derived dendritic cells respond more strongly to CCL19 than to CXCL12: consequences for directional migration.

Humrich JY, Humrich JH, Averbeck M, Thumann P, Termeer C, Kämpgen E, Schuler G, Jenne L.

Immunology. 2006 Feb;117(2):238-47.

7.

Successful treatment of therapy-resistant chronic vegetating pyoderma gangrenosum with infliximab (chimeric antitumour necrosis factor antibody).

Jenne L, Sauter B, Thumann P, Hertl M, Schuler G.

Br J Dermatol. 2004 Feb;150(2):380-2. No abstract available.

PMID:
14996124
8.

Functional analysis of tumor-specific Th cell responses detected in melanoma patients after dendritic cell-based immunotherapy.

Schultz ES, Schuler-Thurner B, Stroobant V, Jenne L, Berger TG, Thielemanns K, van der Bruggen P, Schuler G.

J Immunol. 2004 Jan 15;172(2):1304-10.

9.

Interaction of cutaneous lymphoma cells with reactive T cells and dendritic cells: implications for dendritic cell-based immunotherapy.

Thumann P, Lüftl M, Moc I, Bagot M, Bensussan A, Schuler G, Jenne L.

Br J Dermatol. 2003 Dec;149(6):1128-42.

PMID:
14674889
10.

Leptin concentrations in semen are correlated with serum leptin and elevated in hypergonadotrophic hypogonadism.

von Sobbe HU, Koebnick C, Jenne L, Kiesewetter F.

Andrologia. 2003 Aug;35(4):233-7.

PMID:
12950408
11.

Antigen loading of dendritic cells with whole tumor cell preparations.

Thumann P, Moc I, Humrich J, Berger TG, Schultz ES, Schuler G, Jenne L.

J Immunol Methods. 2003 Jun 1;277(1-2):1-16.

PMID:
12799035
12.

Viral vectors for dendritic cell-based immunotherapy.

Humrich J, Jenne L.

Curr Top Microbiol Immunol. 2003;276:241-59. Review.

PMID:
12797451
13.

DNA viruses and genetic modification of dendritic cells.

Jenne L, Steinkasserer A.

Arch Immunol Ther Exp (Warsz). 2002;50(4):273-7. Review.

PMID:
12371623
14.

Interaction of large DNA viruses with dendritic cells.

Jenne L, Thumann P, Steinkasserer A.

Immunobiology. 2001 Dec;204(5):639-48. Review.

PMID:
11846229
15.

Dendritic cells pulsed with unfractionated helminthic proteins to generate antiparasitic cytotoxic T lymphocyte.

Jenne L, Arrighi JF, Sauter B, Kern P.

Parasite Immunol. 2001 Apr;23(4):195-201.

16.

Viral vectors for dendritic cell-based immunotherapy.

Jenne L, Schuler G, Steinkasserer A.

Trends Immunol. 2001 Feb;22(2):102-7. Review.

PMID:
11286712
17.

Poxvirus as a vector to transduce human dendritic cells for immunotherapy: abortive infection but reduced APC function.

Jenne L, Hauser C, Arrighi JF, Saurat JH, Hügin AW.

Gene Ther. 2000 Sep;7(18):1575-83.

18.

Dendritic cells containing apoptotic melanoma cells prime human CD8+ T cells for efficient tumor cell lysis.

Jenne L, Arrighi JF, Jonuleit H, Saurat JH, Hauser C.

Cancer Res. 2000 Aug 15;60(16):4446-52.

19.

T lymphocyte cytokine profile at a single cell level in alveolar Echinococcosis.

Kilwinski J, Jenne L, Jellen-Ritter A, Radloff P, Flick W, Kern P.

Cytokine. 1999 May;11(5):373-81.

PMID:
10328877
20.

Clinical efficacy of and immunologic alterations caused by interferon gamma therapy for alveolar echinococcosis.

Jenne L, Kilwinski J, Radloff P, Flick W, Kern P.

Clin Infect Dis. 1998 Feb;26(2):492-4.

PMID:
9502476
21.

IL-5 expressed by CD4+ lymphocytes from Echinococcus multilocularis-infected patients.

Jenne L, Kilwinski J, Scheffold W, Kern P.

Clin Exp Immunol. 1997 Jul;109(1):90-7.

22.

Prediction of accelerated cure in Plasmodium falciparum malaria by the elevated capacity of tumor necrosis factor production.

Kremsner PG, Winkler S, Brandts C, Wildling E, Jenne L, Graninger W, Prada J, Bienzle U, Juillard P, Grau GE.

Am J Trop Med Hyg. 1995 Nov;53(5):532-8.

PMID:
7485713
23.

Quinine plus clindamycin improves chemotherapy of severe malaria in children.

Kremsner PG, Radloff P, Metzger W, Wildling E, Mordmüller B, Philipps J, Jenne L, Nkeyi M, Prada J, Bienzle U, et al.

Antimicrob Agents Chemother. 1995 Jul;39(7):1603-5.

24.

Malaria epidemiology in the province of Moyen Ogoov, Gabon.

Wildling E, Winkler S, Kremsner PG, Brandts C, Jenne L, Wernsdorfer WH.

Trop Med Parasitol. 1995 Jun;46(2):77-82.

PMID:
8525289
25.

Comparison of micronized halofantrine with chloroquine-antibiotic combinations for treating Plasmodium falciparum malaria in adults from Gabon.

Kremsner PG, Wildling E, Jenne L, Graninger W, Bienzle U.

Am J Trop Med Hyg. 1994 Jun;50(6):790-5.

PMID:
8024076
26.

High dose chloroquine versus micronized halofantrine in chloroquine-resistant Plasmodium falciparum malaria.

Wildling E, Jenne L, Graninger W, Bienzle U, Kremsner PG.

J Antimicrob Chemother. 1994 Apr;33(4):871-5. No abstract available.

PMID:
8056708
27.

Halofantrine sensitivity.

Wildling E, Winkler S, Brandts C, Jenne L, Graninger W, Wernsdorfer WH, Bienzle U, Kremsner PG.

Lancet. 1993 Jul 3;342(8862):55-6. No abstract available.

PMID:
8100329

Supplemental Content

Support Center